34: Prophylactic oxygen for the prevention of post-cesarean infectious morbidity: a randomized controlled trial

2011 ◽  
Vol 204 (1) ◽  
pp. S20
Author(s):  
Christina Scifres ◽  
Barbara Leighton ◽  
Patricia Fogertey ◽  
George Macones ◽  
David Stamilio
2010 ◽  
Vol 202 (3) ◽  
pp. 310.e1-310.e6 ◽  
Author(s):  
David M. Haas ◽  
Fatemeh Pazouki ◽  
Ronda R. Smith ◽  
Amy M. Fry ◽  
Iwona Podzielinski ◽  
...  

2011 ◽  
Vol 205 (3) ◽  
pp. 267.e1-267.e9 ◽  
Author(s):  
Christina M. Scifres ◽  
Barbara L. Leighton ◽  
Patricia J. Fogertey ◽  
George A. Macones ◽  
David M. Stamilio

2014 ◽  
Vol 66 (3) ◽  
pp. 203-210 ◽  
Author(s):  
N. Russolillo ◽  
A. Ferrero ◽  
L. Vigano’ ◽  
S. Langella ◽  
A. Briozzo ◽  
...  

2020 ◽  
Vol 29 (1S) ◽  
pp. 412-424
Author(s):  
Elissa L. Conlon ◽  
Emily J. Braun ◽  
Edna M. Babbitt ◽  
Leora R. Cherney

Purpose This study reports on the treatment fidelity procedures implemented during a 5-year randomized controlled trial comparing intensive and distributed comprehensive aphasia therapy. Specifically, the results of 1 treatment, verb network strengthening treatment (VNeST), are examined. Method Eight participants were recruited for each of 7 consecutive cohorts for a total of 56 participants. Participants completed 60 hr of aphasia therapy, including 15 hr of VNeST. Two experienced speech-language pathologists delivered the treatment. To promote treatment fidelity, the study team developed a detailed manual of procedures and fidelity checklists, completed role plays to standardize treatment administration, and video-recorded all treatment sessions for review. To assess protocol adherence during treatment delivery, trained research assistants not involved in the treatment reviewed video recordings of a subset of randomly selected VNeST treatment sessions and completed the fidelity checklists. This process was completed for 32 participants representing 2 early cohorts and 2 later cohorts, which allowed for measurement of protocol adherence over time. Percent accuracy of protocol adherence was calculated across clinicians, cohorts, and study condition (intensive vs. distributed therapy). Results The fidelity procedures were sufficient to promote and verify a high level of adherence to the treatment protocol across clinicians, cohorts, and study condition. Conclusion Treatment fidelity strategies and monitoring are feasible when incorporated into the study design. Treatment fidelity monitoring should be completed at regular intervals during the course of a study to ensure that high levels of protocol adherence are maintained over time and across conditions.


Sign in / Sign up

Export Citation Format

Share Document